BDBM563202 2-(3-acetyl-5-(2- methylpyrimidin-5- yl)-1H-indazol-1- yl)-1-((2S,4R)-4- fluoro-2-(5-(4,4,4- trifluorobutyl)- 1,3,4-oxadiazol-2- yl)pyrrolidin-1- yl)ethan-1-one::US11407738, Example 00377

SMILES CC(=O)c1nn(CC(=O)N2C[C@H](F)C[C@H]2c2nnc(CCCC(F)(F)F)o2)c2ccc(cc12)-c1cnc(C)nc1

InChI Key InChIKey=QOJQWGLLDWTYPT-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 563202   

TargetComplement factor D(Human)
Achillion Pharmaceuticals

US Patent
LigandPNGBDBM563202(US11407738, Example 00377 | 2-(3-acetyl-5-(2- meth...)
Affinity DataIC50: 5.50E+3nMAssay Description:Human Factor D (purified from human serum, Complement Technology, Inc.) at 80 nM final concentration is incubated with test compound at various conce...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/28/2022
Entry Details
US Patent